Brief: Biogen And Stoke Therapeutics Present Data That Further Support The Disease-Modifying Potential Of Zorevunersen
05/12/2025 14:02
Dec 5 (Reuters) - Biogen Inc BIIB.O: BIOGEN AND STOKE THERAPEUTICS PRESENT DATA THAT FURTHER SUPPORT THE DISEASE-MODIFYING POTENTIAL OF ZOREVUNERSEN, AN INVESTIGATIONAL MEDICINE FOR THE TREATMENT OF DRAVET SYNDROME, AT THE 2025 AMERICAN EPILEPSY SOCIETY (AES) ANNUAL MEETING Source text: ID:nGNXFdXG1 Further company coverage: BIIB.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Stoke Therapeutics
See all newsBrief: Stoke Therapeutics Announces Inducement Grants
U.S. STOCKS ON THE MOVE-Moderna, O-I Glass, Aveanna Healthcare
U.S. STOCKS ON THE MOVE-NetEase, Werewolf Therapeutics, JP Morgan
U.S. STOCKS ON THE MOVE-Ubiquiti, BJ's Wholesale, Arbutus
U.S. STOCKS ON THE MOVE-Gold miners, Ross Stores, Stoke Therapeutics